ENSC — Ensysce Biosciences Inc · P/E 0.0, rev $5.1M

Ensysce Biosciences Inc (ENSC) is a biotechnology company listed on US.

Latest reported ENSC revenue for 2025-12-31 was $5.1M. Net income was -$10.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. ENSC currently screens at market cap $5.2M and trailing P/E 0.0.

Use this ENSC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ENSC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ENSC SEC filings page. Lician reads the product cache first so this HTML stays unique to Ensysce Biosciences Inc even when a live quote feed is slow.

Ensysce Biosciences Inc latest statements (FY2025)

Latest cached year on this hub. Full ENSC income, balance, and cash tables.

  • Revenue$5.1M
  • Net Income-$10.2M
  • Total Assets$7.5M
  • Total Debt$0
  • Free Cash Flow-$7.9M

ENSC recent filings